In the First Year after Its Approval for Psoriasis, Nearly One-Half of ... - Business Wire (press release)

In the archetypal Year after Its approving for Psoriasis , just about One-Half of ... business concern Wire (press release) (BUSINESS WIRE)--Decision Resources, one of the world's leading investigating and advisory firms for pharmaceutical and healthcare issues, finds that, in the first year following its approval for psoriasis , nearly one-half (46 percent) of surveyed ... and more » Link To Article